Insider Trading Alert - AMRS, MKTX And CERN Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 12, 2015, 114 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $4,322,819.24.

Highlighted Stocks Traded by Insiders:

Amyris (AMRS) - FREE Research Report

Melo John, who is President and CEO at Amyris, sold 65,575 shares at $2.08 on May 12, 2015. Following this transaction, the President and CEO owned 340,942 shares meaning that the stake was reduced by 16.13% with the 65,575-share transaction.

The shares most recently traded at $1.99, down $0.09, or 4.53% since the insider transaction. Historical insider transactions for Amyris go as follows:

  • 4-Week # shares sold: 172,186
  • 12-Week # shares sold: 172,186
  • 24-Week # shares sold: 172,186

The average volume for Amyris has been 176,900 shares per day over the past 30 days. Amyris has a market cap of $164.6 million and is part of the basic materials sector and chemicals industry. Shares are unchanged year-to-date as of the close of trading on Tuesday.

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products for the consumer care, specialty chemical, and transportation fuel markets worldwide. Currently, there are no analysts who rate Amyris a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMRS - FREE

TheStreet Quant Ratings rates Amyris as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, poor profit margins and generally disappointing historical performance in the stock itself. Get the full Amyris Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

MarketAxess Holdings (MKTX) - FREE Research Report

McVey Richard M, who is Chairman & CEO at MarketAxess Holdings, sold 40,000 shares at $85.56 on May 12, 2015. Following this transaction, the Chairman & CEO owned 1.1 million shares meaning that the stake was reduced by 3.54% with the 40,000-share transaction.

The shares most recently traded at $86.43, up $0.87, or 1.01% since the insider transaction. Historical insider transactions for MarketAxess Holdings go as follows:

  • 4-Week # shares sold: 4,375
  • 12-Week # shares sold: 16,605
  • 24-Week # shares sold: 34,613

The average volume for MarketAxess Holdings has been 212,400 shares per day over the past 30 days. MarketAxess Holdings has a market cap of $3.2 billion and is part of the financial sector and financial services industry. Shares are up 20.03% year-to-date as of the close of trading on Tuesday.

Marketaxess Holdings Inc., together with its subsidiaries, operates an electronic trading platform that enables fixed-income market participants to trade corporate bonds and other types of fixed-income instruments worldwide. The stock currently has a dividend yield of 0.93%. The company has a P/E ratio of 39.9. Currently, there are no analysts who rate MarketAxess Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MKTX - FREE

TheStreet Quant Ratings rates MarketAxess Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, reasonable valuation levels, expanding profit margins and solid stock price performance. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full MarketAxess Holdings Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cerner (CERN) - FREE Research Report

Zollars William D, who is Director at Cerner, sold 7,400 shares at $67.63 on May 12, 2015. Following this transaction, the Director owned 58,266 shares meaning that the stake was reduced by 11.27% with the 7,400-share transaction.

The shares most recently traded at $67.57, down $0.06, or 0.09% since the insider transaction. Historical insider transactions for Cerner go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 14,197

The average volume for Cerner has been 1.6 million shares per day over the past 30 days. Cerner has a market cap of $23.4 billion and is part of the technology sector and computer software & services industry. Shares are up 5.32% year-to-date as of the close of trading on Tuesday.

Cerner Corporation designs, develops, markets, installs, hosts, and supports healthcare information technology, healthcare devices, hardware, and content solutions for healthcare organizations and consumers in the United States and internationally. The company has a P/E ratio of 46.0. Currently, there are 20 analysts who rate Cerner a buy, no analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CERN - FREE

TheStreet Quant Ratings rates Cerner as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cerner Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Mattel CEO Georgiadis Expected to Drive Tech Growth

Mattel CEO Georgiadis Expected to Drive Tech Growth

Demand for Aviation Biofuels Grows as Green Regulations Loom

Demand for Aviation Biofuels Grows as Green Regulations Loom

7 Stocks Under $10 to Trade for Big Profits

7 Stocks Under $10 to Trade for Big Profits

6 Stocks Under $10 to Trade for Breakouts

6 Stocks Under $10 to Trade for Breakouts

3 Stocks Improving Performance Of The Chemicals Industry

3 Stocks Improving Performance Of The Chemicals Industry